Thematic-based: Legal Practice in the Healthcare Business

Chapter 1 Healthcare and M&A

Chapter 2 Healthcare and Patents

Chapter 3 Healthcare and Licensing

Chapter 4 Healthcare and Product Liability/Recall

Chapter 5 Healthcare and the Anti-monopoly Act

Chapter 6 Healthcare and Compliance with Laws and Regulations

Please see further details on this book at the website of CHUOKEIZAI-SHA HOLDINGS, INC.: Here

Authors： Hirotake Tanaka Toshiya Furusho Takashi Koyama Takashi Hirose Yugo Komori Kosuke Yoshimura Shingo Yamada Yuki Kuroda
Publisher：CHUOKEIZAI-SHA HOLDINGS, INC.
Practice： Protection of Personal Information Research and Development Marketing Regulation Labelling and Advertising regulation Dispute Resolution Crisis Management M&A Cosmetics & Health/Beauty Care Products Intellectual Property Transactions Unfair Competition Intellectual Property Dispute Resolution Competition/Consumer Protection Compliance
Date of publication： July 28, 2023

Other publications by Hirotake Tanaka

2023.08.08
Bankruptcy of a Party that Agreed to Resolve Disputes through Arbitration Proceedings
2022.01.11
Are bankruptcy creditors expected to pay attention to public announcements in the official gazette? (decision of the Utsunomiya District Court on May 13, 2021, Hanrei Times No. 1489, p. 69)
2021.06.08
A Case in Which the Right of Avoidance was Held to be Established with Respect to a Notice of Shortfall in So-called “Kizoku-seisan (Liquidation of Security While Retaining Ownership)” (Judgment by the Osaka District Court on December 20, 2019)
2020.08.11
Points to Consider for Open Innovation from the Perspective of Insolvency Law (Referring to a Joint R&D Agreement with a Start-up)
2020.03.10
Bankruptcy of Licensor and the Consequences for License Agreements
2019.12.10
Various Aspects of the US Bankruptcy Law #6 –Validity of Contract Termination on the Basis of “Filing Bankruptcy”
2019.07.09
Various Aspects of the US Bankruptcy Law #5 –Venue for Chapter 11 filings
2019.06.11
Various Aspects of the US Bankruptcy Law #4 –Can Receivables be Collected through Offsetting?
2019.05.14
M&A in the Framework of Statutory Insolvency Procedures
2019.02.12
Various Aspects of the US Bankruptcy Law #3 – Automatic Stay Ⅱ
2018.12.21
FAQ on Investments in Medical Organizations
2018.12.11
Various Aspects of the US Bankruptcy Law #2 – Automatic Stay I
2018.10.10
Various aspects of US Bankruptcy Law #1 - How bankruptcy is viewed differently in Japan and the United States
2015.12.15
Commentaries on the Bankruptcy Act (Vol. 1)
2014.02.25
New Approach for the Use of Corporate Reorganization Proceedings – The case in which, after having been shifted from a civil rehabilitation case to a bankruptcy case, the bankruptcy trustee filed a petition to commence corporate reorganization proceedings and, under such corporate reorganization proceedings, the trustee successfully formed an agreement with secured creditors and disposed the building built on leased land, including completed parts of construction (concrete basement and the like) thereof

MORE

Other publications by Toshiya Furusho

2022.12.16
JAPAN: An Introduction to Intellectual Property: Bengoshi
2022.07.15
The Intellectual Property and Antitrust Review 7th edition Japan Part
2021.07.15
The Intellectual Property and Antitrust Review 6th edition Japan Part
2021.04.08
International Advertising Law：Second Edition［JAPAN］
2020.07.01
The Intellectual Property and Antitrust Review 5th edition Japan Part
2019.12.20
International Legal Practice
2019.11.02
Legal Practice Concerning Joint Research and Development Agreements
2017.06.27
Supreme Court Decision on the Fifth Requirement of the Doctrine of Equivalents - DKSH Japan K.K. et al. v. Chugai Pharmaceutical Co. Ltd. (the "Maxacalcitol Case")
2014.05.01
International Advertising Law [Japan]
2014.04.01
Unfair Competition
2010.11.19
Exhaustion of a Patent – The Ink Cartridge Case

MORE

Other publications by Takashi Koyama

2026.02.16
Sanctions 2025 - Japan Trends and Developments
2026.01.26
The Legal 500 Country Comparative Guides - Japan Investing In
2025.01.10
The Legal 500 Country Comparative Guides - Japan Investing In
2024.04.10
Foreign Filling Restrictions of Major Countries －Mechanisms to Restrict Foreign Filing of Sensitive Inventions－
2024.01.17
The Legal 500 Country Comparative Guides - Japan Investing In
2023.11.20
Inventions Made Across Boarders and the Attachment Foreign Filling Restrictions: Conflicts in the Restrictions and How They Are Handled
2023.08.25
National Security and Business: Conflict of Nations and Regulation of Specific Companies
2022.03.11
A study of the secret patent systems of various countries, and the introduction of the same system in Japan (No.2)(end)
2022.02.14
A study of the secret patent systems of various countries, and the introduction of the same system in Japan (No.1)
2021.12.01
A Detailed Explanation of Economic Partnership Agreements
2021.10.01
Obligation to Conclude Multilateral Treaties in the Field of Intellectual Property through FTA/EPA - Efforts to Strengthen Protection of Rights and to Achieve International Harmonization of Systems -
2021.03.31
Protection of Geographical Indications under the TPP and Japan-EU Economic Partnership Agreement (EPA)
2021.03.26
Selected Intellectual Property Issues under the TPP and Japan-EU EPA
2020.01.01
Dictionary of Contract Terms (Revised Edition)
2019.01.01
Business and IP commitments in Economic Partnership Agreements (EPAs)
2017.05.01
JAPAN Section/Protection and Disclosure of Trade Secrets and Know-How
2015.04.01
The Existence of a “Dispute” and the Prima Facie Test for a Tribunal to Have Jurisdiction
2015.03.01
Handbook on Joint Research and Development Agreement
2015.02.01
Reading of U.S. Supreme Court Cases: Commentary on Intellectual Property and Business Cases in the 21st Century
2014.05.01
Document Production Procedure and the Scope of Privilege in Investment Treaty Arbitration
2012.12.01
Indirect Expropriation, Fair and Equitable Treatment Obligations, and Valuation Standards and Methods of Damages under CAFTA
2011.12.01
The investment treaty arbitration decision finding that (i) the change of tax scheme after the investments and demands to hire a given level of nationals did not constitute a breach of the Fair and Equitable Treatment (FET) obligations and that (ii) a breach of contract by the central bank constituted a breach of the ‘expanded’ FET obligations imported through the MFN clause.
2011.08.01
Dictionary of Contract Terms
2010.09.01
Intellectual Property Commitments in Japan's Economic Partnership Agreements (EPAs)
2010.01.01
Negotiations regarding Intellectual Property in Economic Partnership Agreements (EPAs), [1] - [9]
2007.05.01
Commentary on FTA/EPA Negotiations

MORE

Other publications by Takashi Hirose

2024.01.12
Business Use of Generative AI (Part II) - Formulation of Internal Rules Regarding Use of Generative AI
2023.05.20
Japan M&A - Key Intellectual Property Issues in M&A Transactions -
2022.12.16
JAPAN: An Introduction to Intellectual Property: Bengoshi
2022.07.15
The Intellectual Property and Antitrust Review 7th edition Japan Part
2022.07.06
Information Compromised by a Cyber Attack! What is the Legal Responsibility of the Company?
2022.05.18
Japan M&A - Key Intellectual Property Issues in M&A Transactions -
2022.04.27
A comparison of trademark frameworks: Japan
2022.04.01
Practical Points of System Development as Suggested by the High Court Decision in Nomura HD and Nomura Securities v. IBM Japan
2021.07.15
The Intellectual Property and Antitrust Review 6th edition Japan Part
2021.05.01
Japan M&A - Key Intellectual Property Issues in M&A Transactions -
2020.12.21
2021 Book Guide for Legal Affairs "Updates to Common Business Sense in Response to Changes in the Social Environment" -Business Law Journal, February 2021 Issue
2020.07.31
How to Proceed with Joint Research and Development and Legal Points to Note therein（Chapter 4: Section 1 "Points on Patent License Agreement and Way of thinking on Provisions"）
2020.07.01
The Intellectual Property and Antitrust Review 5th edition Japan Part
2019.08.01
The Revised Civil Code and Practices on Insurance Business
2018.10.19
Overview of corporate responsibilities for an important misstatement in a securities report due to fraudulent accounting
2018.09.06
Points on Provisions of Patent License Agreement - Based on Revision of Civil Code -
2016.12.15
Web Commentary on TPP "2.4 National Treatment and Market Access for Goods (Agriculture)"
2016.09.30
Revisions to Employee Invention Provisions under the Patent Act

MORE

Other publications by Yugo Komori

2019.08.01
The Revised Civil Code and Practices on Insurance Business
2019.06.28
Safety Regulations for Consumer Products in Japan
2016.01.01
Various Practical Issues concerning Product Liability (PL) – Examination of the Warning Defect
2012.11.01
Product Recall, Liability and Insurance
2012.10.01
Various Practical Issues concerning Product Liability (PL) – Based on Recent Cases

MORE

Other publications by Kosuke Yoshimura

2025.02.01
Outline of the Freelance Act and Practical Points to Note
2024.04.19
Cartels Laws and Regulations 2024 - Japan Chapter
2023.05.02
GLI Cartels 2023 - Japan Chapter
2022.05.13
The Legal 500 Country Comparative Guides - Japan CARTELS
2022.02.04
Antimonopoly Act Consultation Handbook
2021.10.05
The Legal 500 Comparative Guides - Japan Merger Control
2021.03.01
COVID-19 and Corporate Legal Affairs – Legal Issues during/after COVID-19
2020.12.21
Amendments to the Antimonopoly Act
2020.11.20
Corporate Compliance on Utilization of External Human Resources - Intersection of Antimonopoly Act and Employment Law
2020.10.31
Practical Guide to the 2016 and 2019 Antimonopoly Act Amendments
2020.10.07
Extraterritorial Application of EU Cartel Regulations
2020.07.15
Detection by US Authorities of Cartels that include Japanese Companies, and the Risk of Extradition to the United States for Officers and Employees Residing in Japan
2020.06.18
Extraterritorial Application of U.S. Cartel Regulations
2019.09.30
Cartel Regulation and State of Enforcement in Foreign Countries
2019.03.01
Schmidt's Deodorant Company (Natural Deodorant Products), Report #6127, NAD/CARU Case Reports (10/27/2017) - A Case Study where Advertising Claims based on General Customers' Reviews were Found Inappropriate in the US -
2019.01.01
[Health Promotion Act/Act Against Unjustifiable Premiums and Misleading Representations] Health Foods and Labeling Regulations
2018.10.03
Points to Note in the Consumer Contract Act Amended in 2018 and Measures Required of Corporations
2016.08.01
BUSINESS LAWYERS website (August 2016 -)

MORE

Other publications by Shingo Yamada

2019.12.21
What manufacturers need to do in case of incidents caused by their consumer products
2019.12.20
International Legal Practice
2019.02.22
Response to Accidents Involving Consumer Products
2017.06.27
Recent Tightening of Enforcement of the Subcontract Act
2016.10.07
Web Commentary on TPP "4　Textile and Apparel Goods"
2013.03.15
The Differences between Japan and the United States in the Protection of Attorney-Client Communications

MORE

Other publications by Yuki Kuroda

2025.08.04
Doing Business In... 2025 Trends and Developments
2025.04.01
Current Status of “The Every-Three-Year Review ” of the Act on the Protection of Personal Information: Changes in Enforcement Proceedings and Effects for AI Development, etc.
2025.03.15
Data Protection & Privacy 2025 - Japan Trends and Developments
2024.07.19
Doing Business In... 2024 Trends and Developments
2023.07.18
Doing Business In... 2023 Trends and Developments
2022.07.12
Doing Business In... 2022 Trends and Developments
2021.07.14
Doing Business In... 2021 Japan 　Trends and Developments
2021.04.08
International Advertising Law：Second Edition［JAPAN］
2021.03.01
COVID-19 and Corporate Legal Affairs – Legal Issues during/after COVID-19
2019.12.20
International Legal Practice
2018.12.14
Enforcement and Impact of the Clinical Trial Act
2017.06.01
Practical points of processing of personal data in the context of R&D
2017.03.31
The Supreme Court Disallowed the Deletion of Google's Search Results
2016.10.01
U.S. Health Information Protection System under HIPAA and Related Rules - Overview and Cases
2016.07.15
Information Disclosure Requirements in the U.S. Healthcare Industry (under the U.S. Sunshine Act)
2015.05.26
Joint R&D Agreement Handbook- Practices and Examples of Japanese-English Provisions
2015.04.01
Handbook on Joint Research and Development Agreements — Practices and Sample Provisions in Japanese and English

MORE

Other publications about Cosmetics & Health/Beauty Care Products

2023.08.24
Thematic-based: Legal Practice in the Healthcare Business
2023.02.27
China’s Life Science and Healthcare-No.3 Amendment of the Regulations on Cosmetics in China
2023.01.20
Legal Affairs for Chinese Life Sciences and Healthcare No.15: System of the Person Responsible for the Production Safety (Safety Officer) of Food and Food-related Products in China
2022.07.04
China’s Life Sciences and Healthcare-No.2 －The Good Vigilance Practice rule in China
2022.05.26
Legal Affairs for Chinese Life Sciences and Healthcare (Part 10) - Toward the Enforcement of the New Cosmetics GMP
2022.04.27
Legal Affairs for Chinese Life Sciences and Healthcare (Part 9) - [Subsidiary Regulations on Administrative Measures for Monitoring of Adverse Reactions to Cosmetics] Overview
2022.03.24
Legal Affairs for Chinese Life Sciences and Healthcare (Part 8) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the Subsidiary Regulations on Administration Measures for Cosmetics Manufacture and Operation and the GMP for Cosmetics (3)
2022.03.14
A Legal Review of China’s Life Sciences and 2 Healthcare- No.1 －General Introduction and MAH System
2022.02.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 7) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the Subsidiary Regulations on Administration Measures for Cosmetics Manufacture and Operation and the GMP for Cosmetics (2)
2022.01.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 5) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the Subsidiary Regulations on Administration Measures for Cosmetics Manufacture and Operation and the GMP for Cosmetics (1)
2021.11.24
Legal Affairs for Chinese Life Sciences and Healthcare (Part 4) – Developments in Amendment of Regulations Concerning Wholesaling/Retailing of Pharmaceutical Products, Etc. (Measures on Supervision and Control of the Drug Business and Usage Quality (Draft for Comment))
2021.10.28
Legal Affairs for Chinese Life Sciences and Healthcare (Part 3) – Approaching the implementation of China GVP (Good Pharmacovigilance Practice) (effective from December 1, 2021) (2)
2021.09.30
Legal Affairs for Chinese Life Sciences and Healthcare (Part 2) –Approaching the implementation of China GVP (Good Pharmacovigilance Practice) (effective from December 1, 2021) (1)
2021.08.30
Legal Affairs for Chinese Life Sciences and Healthcare

MORE

Other publications about Research and Development

2025.11.28
Legal Affairs for Chinese Life Sciences and Healthcare No. 26: Progress in Domestic Manufacturing Policies for Medical Devices
2025.09.25
Legal Affairs for Chinese Life Sciences and Healthcare No. 25: Update on the Amendments to China’s Medical Device Laws and Regulations
2025.05.27
Legal Affairs for Chinese Life Sciences and Healthcare No. 24: Update on the Revisions to Chinese Pharmaceutical Regulations
2025.03.24
Legal Affairs for Chinese Life Sciences and Healthcare No. 23: Updates on the Amendments of Pharmaceutical Laws and Regulations of China
2023.08.24
Thematic-based: Legal Practice in the Healthcare Business
2022.07.04
China’s Life Sciences and Healthcare-No.2 －The Good Vigilance Practice rule in China
2022.03.14
A Legal Review of China’s Life Sciences and 2 Healthcare- No.1 －General Introduction and MAH System
2022.02.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 7) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the Subsidiary Regulations on Administration Measures for Cosmetics Manufacture and Operation and the GMP for Cosmetics (2)
2022.01.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 5) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the Subsidiary Regulations on Administration Measures for Cosmetics Manufacture and Operation and the GMP for Cosmetics (1)
2021.11.24
Legal Affairs for Chinese Life Sciences and Healthcare (Part 4) – Developments in Amendment of Regulations Concerning Wholesaling/Retailing of Pharmaceutical Products, Etc. (Measures on Supervision and Control of the Drug Business and Usage Quality (Draft for Comment))
2021.10.28
Legal Affairs for Chinese Life Sciences and Healthcare (Part 3) – Approaching the implementation of China GVP (Good Pharmacovigilance Practice) (effective from December 1, 2021) (2)
2021.09.30
Legal Affairs for Chinese Life Sciences and Healthcare (Part 2) –Approaching the implementation of China GVP (Good Pharmacovigilance Practice) (effective from December 1, 2021) (1)
2021.08.30
Legal Affairs for Chinese Life Sciences and Healthcare

MORE

Other publications about Crisis Management

2024.07.01
Response to the Press as Part of Corporate Risk Management
2023.08.24
Thematic-based: Legal Practice in the Healthcare Business
2022.04.27
Legal Affairs for Chinese Life Sciences and Healthcare (Part 9) - [Subsidiary Regulations on Administrative Measures for Monitoring of Adverse Reactions to Cosmetics] Overview
2022.03.20
Re-examination of Companies' Actions Regarding the Whistleblower Hotline -- In View of Upcoming Enforcement of the Amended Whistleblower Protection Act
2022.01.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 5) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the Subsidiary Regulations on Administration Measures for Cosmetics Manufacture and Operation and the GMP for Cosmetics (1)

MORE

Other publications about Labelling and Advertising regulation

2025.05.27
Legal Affairs for Chinese Life Sciences and Healthcare No. 24: Update on the Revisions to Chinese Pharmaceutical Regulations
2025.03.24
Legal Affairs for Chinese Life Sciences and Healthcare No. 23: Updates on the Amendments of Pharmaceutical Laws and Regulations of China
2025.01.10
Recent Discussions Concerning Distribution of Digital Advertisements and Reponses of Related Business Operators
2024.09.26
Legal Affairs for Chinese Life Sciences and Healthcare No. 22: Shanghai Cosmetics Industry Advertising Compliance Guidelines
2023.08.24
Thematic-based: Legal Practice in the Healthcare Business
2022.10.25
Legal Affairs for Chinese Life Sciences and Healthcare (Part 13) -Chinese Regulations on Labeling and Advertisement for Cosmetics-
2022.03.14
A Legal Review of China’s Life Sciences and 2 Healthcare- No.1 －General Introduction and MAH System
2022.02.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 7) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the Subsidiary Regulations on Administration Measures for Cosmetics Manufacture and Operation and the GMP for Cosmetics (2)
2022.01.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 5) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the Subsidiary Regulations on Administration Measures for Cosmetics Manufacture and Operation and the GMP for Cosmetics (1)
2022.01.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 6) - Trial Program for Cross-border E-commerce Retail Import of Drugs in Henan
2021.04.08
International Advertising Law：Second Edition［JAPAN］

MORE

Other publications about Intellectual Property Dispute Resolution

2025.07.29
Pantech v Google: Tokyo District Court grants first injunction for SEP infringement（Co-authored）
2024.05.01
Legal Issues Related to Generative AI
2024.04.20
Judgment in Which the Court Determined Whether or Not the Relevant Act Constitutes an Indirect Infringement by a Non-Exclusive Article (Item 2, Article 101 of the Patent Act) Pertaining to Invention of a Product- Requirements for Indirect Infringement by Non-Exclusive Article -
2023.08.24
Thematic-based: Legal Practice in the Healthcare Business
2023.02.28
National Comparison Tables - Japan part
2022.03.01
Summary of Countermeasures for Counterfeit Products in the US
2022.02.04
A Case in Which the Applicability of Article 3, Paragraph 1, Item 3 of the Trademark Act was Disputed with Respect to the Trademark “VEGAS” (Intellectual Property Newsletter (2022 February Issue))
2021.12.01
A Detailed Explanation of Economic Partnership Agreements
2021.08.05
A Case in Which a Court Admission Rendered in the First Trial was Overturned upon Considering Issues of Conventional Technology and Revising Judgment Based on the Fulfillment Theory (Intellectual Property Newsletter (2021 August Issue))
2021.05.07
A Case in Which the Japan Patent Office and the Court Reached Different Decisions Regarding Similarity in the Inventive Step of Two Inventions (Intellectual Property Newsletter (2021 May Issue))
2021.04.01
Patent Enforcement Practices Before, During and After Patent Litigation Proceedings in Japan – A Comparative Analysis with Germany and the United States –
2021.03.05
A Case Involving a Dispute Over Similarity of Trademarks and Other Matters Related to Services Supporting Job Seeking Activities by Currently Unemployed Recent Graduates with Work Experience (Intellectual Property Newsletter (2021 March Issue))
2021.01.26
Intellectual Property Newsletter (Digest version) (2021 Winter Issue) Key Points in Reading Case Reports
2021.01.01
The Ways of Limiting Injunctive Relief in Patent Infringement Litigation and their Effects – Current Japanese Practices and Suggestions for their Future Improvements, based on the Recent Trends in Germany and the United States –
2019.01.01
Business and IP commitments in Economic Partnership Agreements (EPAs)
2018.03.21
The Compass for Intellectual Property Law - The Supreme Court Ruled on a Re-defense based on a Correction of Claims against a Patent Invalidity Defense in a Patent Infringement Case
2018.03.01
IP Laws of the Philippines
2018.02.19
Q&A on the Actual Practice of Employee Inventions (Keiso’s Law and Practice Series)(co-author)
2015.02.01
Reading of U.S. Supreme Court Cases: Commentary on Intellectual Property and Business Cases in the 21st Century
2007.05.01
Commentary on FTA/EPA Negotiations
2006.04.01
Guide to International Legal Practice (1) to (11)

MORE

Other publications about Marketing Regulation

2025.11.28
Legal Affairs for Chinese Life Sciences and Healthcare No. 26: Progress in Domestic Manufacturing Policies for Medical Devices
2025.09.25
Legal Affairs for Chinese Life Sciences and Healthcare No. 25: Update on the Amendments to China’s Medical Device Laws and Regulations
2025.05.27
Legal Affairs for Chinese Life Sciences and Healthcare No. 24: Update on the Revisions to Chinese Pharmaceutical Regulations
2025.04.01
Direction of the Revision of the Pharmaceutical and Medical Device Act and Related Systems - Quality Assurance, Stable Supply, Support for Drug Discovery, Development of Pharmacy Functions, etc.
2025.03.24
Legal Affairs for Chinese Life Sciences and Healthcare No. 23: Updates on the Amendments of Pharmaceutical Laws and Regulations of China
2024.01.24
Legal Affairs for Chinese Life Sciences and Healthcare No. 21: Revision to the Administrative Regulation on Wholesale, Retail, etc., of Pharmaceutical Products (Establishment of the Regulation on Supervision and Administration of Business Management and Quality of Pharmaceutical Products)
2023.11.28
Legal Affairs for Chinese Life Sciences and Healthcare No. 20: Notice on Enhancing the Supervision and Administration of Contract Manufacture of Drug Marketing Authorization Holders (No. 132 of 2023)
2023.08.24
Thematic-based: Legal Practice in the Healthcare Business
2022.07.04
China’s Life Sciences and Healthcare-No.2 －The Good Vigilance Practice rule in China
2022.05.26
Legal Affairs for Chinese Life Sciences and Healthcare (Part 10) - Toward the Enforcement of the New Cosmetics GMP
2022.03.24
Legal Affairs for Chinese Life Sciences and Healthcare (Part 8) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the Subsidiary Regulations on Administration Measures for Cosmetics Manufacture and Operation and the GMP for Cosmetics (3)
2022.02.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 7) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the Subsidiary Regulations on Administration Measures for Cosmetics Manufacture and Operation and the GMP for Cosmetics (2)
2022.01.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 5) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the Subsidiary Regulations on Administration Measures for Cosmetics Manufacture and Operation and the GMP for Cosmetics (1)
2022.01.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 6) - Trial Program for Cross-border E-commerce Retail Import of Drugs in Henan
2021.11.24
Legal Affairs for Chinese Life Sciences and Healthcare (Part 4) – Developments in Amendment of Regulations Concerning Wholesaling/Retailing of Pharmaceutical Products, Etc. (Measures on Supervision and Control of the Drug Business and Usage Quality (Draft for Comment))
2021.10.28
Legal Affairs for Chinese Life Sciences and Healthcare (Part 3) – Approaching the implementation of China GVP (Good Pharmacovigilance Practice) (effective from December 1, 2021) (2)

MORE

Other publications about Unfair Competition

2025.07.24
Amendments to the Unfair Competition Prevention Act
2025.01.10
Basic Knowledge Concerning Trade Secrets – Recent Court Decisions and Management as Confidential Information
2024.07.24
Brief Analysis of the Provisional Rules for the Prevention of Unfair Network Competition
2024.01.12
Business Use of Generative AI (Part II) - Formulation of Internal Rules Regarding Use of Generative AI
2024.01.12
Business Use of Generative AI (Part I) - Legal Considerations for Use Cases for Each Department
2024.01.12
Outline of Act for Partial Revision of the Unfair Competition Prevention Act, etc.
2023.08.24
Thematic-based: Legal Practice in the Healthcare Business
2023.02.28
National Comparison Tables - Japan part
2022.03.01
Summary of Countermeasures for Counterfeit Products in the US
2020.06.27
Lawyers' Knowledge on Competition Law Practice
2017.11.27
Lecture on Practices of the U.S. Antitrust Laws
2017.05.01
JAPAN Section/Protection and Disclosure of Trade Secrets and Know-How
2015.03.01
Handbook on Joint Research and Development Agreement

MORE

Other publications about Intellectual Property Transactions

2025.09.26
Patent Utilization Strategies: Patent Funds and Key Contractual Considerations
2025.07.01
Strategies for Patent Utilization – Overview of Patent Funds and Points in Concluding Contracts -
2024.09.27
Some Legal Issues Concerning the Use of Copyrighted Works in the Development and Learning Phases of Generative AI
2024.05.01
Legal Issues Related to Generative AI
2024.04.20
Judgment in Which the Court Determined Whether or Not the Relevant Act Constitutes an Indirect Infringement by a Non-Exclusive Article (Item 2, Article 101 of the Patent Act) Pertaining to Invention of a Product- Requirements for Indirect Infringement by Non-Exclusive Article -
2024.04.10
Foreign Filling Restrictions of Major Countries －Mechanisms to Restrict Foreign Filing of Sensitive Inventions－
2023.11.20
Inventions Made Across Boarders and the Attachment Foreign Filling Restrictions: Conflicts in the Restrictions and How They Are Handled
2023.08.24
Thematic-based: Legal Practice in the Healthcare Business
2023.05.20
Japan M&A - Key Intellectual Property Issues in M&A Transactions -
2023.04.03
Avatarization of Celebrities and Contractual Practices in the Metaverse
2023.02.28
National Comparison Tables - Japan part
2022.12.16
JAPAN: An Introduction to Intellectual Property: Bengoshi
2022.10.03
Protection of Image Designs and Spatial Designs - Status and Practical Response after the 2019 Amendment to the Design Law
2022.07.15
The Intellectual Property and Antitrust Review 7th edition Japan Part
2022.05.18
Japan M&A - Key Intellectual Property Issues in M&A Transactions -
2022.03.11
A study of the secret patent systems of various countries, and the introduction of the same system in Japan (No.2)(end)
2022.03.01
Summary of Countermeasures for Counterfeit Products in the US
2022.02.17
NFT Mechanism and Legal Issues of NFT Transactions
2022.02.14
A study of the secret patent systems of various countries, and the introduction of the same system in Japan (No.1)
2022.02.04
A Case in Which the Applicability of Article 3, Paragraph 1, Item 3 of the Trademark Act was Disputed with Respect to the Trademark “VEGAS” (Intellectual Property Newsletter (2022 February Issue))
2022.01.12
Subject Matter of License and “Implied License” under Patent License Agreements Written in English
2021.12.23
Latest Developments in the Japanese Patent Practice
2021.12.01
A Detailed Explanation of Economic Partnership Agreements
2021.10.01
Obligation to Conclude Multilateral Treaties in the Field of Intellectual Property through FTA/EPA - Efforts to Strengthen Protection of Rights and to Achieve International Harmonization of Systems -
2021.08.05
A Case in Which a Court Admission Rendered in the First Trial was Overturned upon Considering Issues of Conventional Technology and Revising Judgment Based on the Fulfillment Theory (Intellectual Property Newsletter (2021 August Issue))
2021.07.15
The Intellectual Property and Antitrust Review 6th edition Japan Part
2021.05.07
A Case in Which the Japan Patent Office and the Court Reached Different Decisions Regarding Similarity in the Inventive Step of Two Inventions (Intellectual Property Newsletter (2021 May Issue))
2021.05.01
Japan M&A - Key Intellectual Property Issues in M&A Transactions -
2021.03.31
Protection of Geographical Indications under the TPP and Japan-EU Economic Partnership Agreement (EPA)
2021.03.05
A Case Involving a Dispute Over Similarity of Trademarks and Other Matters Related to Services Supporting Job Seeking Activities by Currently Unemployed Recent Graduates with Work Experience (Intellectual Property Newsletter (2021 March Issue))
2021.01.26
Intellectual Property Newsletter (Digest version) (2021 Winter Issue) Key Points in Reading Case Reports
2020.12.21
2021 Book Guide for Legal Affairs "Updates to Common Business Sense in Response to Changes in the Social Environment" -Business Law Journal, February 2021 Issue
2020.07.31
How to Proceed with Joint Research and Development and Legal Points to Note therein（Chapter 4: Section 1 "Points on Patent License Agreement and Way of thinking on Provisions"）
2020.07.01
The Intellectual Property and Antitrust Review 5th edition Japan Part
2019.01.01
Business and IP commitments in Economic Partnership Agreements (EPAs)
2018.09.06
Points on Provisions of Patent License Agreement - Based on Revision of Civil Code -
2018.08.28
The Act on Special Measures for Productivity Improvement (Part 2) - Outline of the System to Facilitate Data Sharing and Collaboration
2018.08.10
The Act on Special Measures for Productivity Improvement (Part 1) - What does the “Regulatory Sandbox” mean?
2018.03.21
The Compass for Intellectual Property Law - The Supreme Court Ruled on a Re-defense based on a Correction of Claims against a Patent Invalidity Defense in a Patent Infringement Case
2018.03.01
IP Laws of the Philippines
2018.02.19
Q&A on the Actual Practice of Employee Inventions (Keiso’s Law and Practice Series)(co-author)
2017.05.01
JAPAN Section/Protection and Disclosure of Trade Secrets and Know-How
2015.03.01
Handbook on Joint Research and Development Agreement
2015.02.01
Reading of U.S. Supreme Court Cases: Commentary on Intellectual Property and Business Cases in the 21st Century
2010.09.01
Intellectual Property Commitments in Japan's Economic Partnership Agreements (EPAs)
2010.01.01
Negotiations regarding Intellectual Property in Economic Partnership Agreements (EPAs), [1] - [9]
2007.05.01
Commentary on FTA/EPA Negotiations

MORE

Other publications about Dispute Resolution

2023.08.24
Thematic-based: Legal Practice in the Healthcare Business

MORE

Other publications about Competition/Consumer Protection Compliance

2025.11.19
PANORAMIC - Government Investigations 2026 - Japan Chapter
2025.07.01
Key Points of the Revised Subcontract Act (the Act on Prevention of Delays in Payment of Fees to Small and Medium-sized Contractors for Manufacturing and Other Services)
2025.02.01
Outline of the Freelance Act and Practical Points to Note
2024.07.18
PANORAMIC - Government Investigations 2025 - Japan Chapter
2024.04.19
Cartels Laws and Regulations 2024 - Japan Chapter
2023.08.24
Thematic-based: Legal Practice in the Healthcare Business
2023.07.28
Getting the Deal Through - Government Investigations 2024 - Japan Chapter
2023.07.03
Overview of and Response to Stealth Marketing Regulations to be Introduced
2023.07.03
2021 Revised Act on Specified Commercial Transactions and Summary
2023.05.02
GLI Cartels 2023 - Japan Chapter
2022.09.27
Summary of the Amendment to the Chinese Anti-Monopoly Law (2) – Monopoly agreements and abuses of dominant market positions
2022.05.21
Understanding the Basics - The Regulatory Framework of Subcontracting-related Laws (Business Homu, July 2022)
2022.05.13
The Legal 500 Country Comparative Guides - Japan CARTELS
2022.02.15
Utilization of Antimonopoly Act in Civil Dispute Resolution
2022.02.04
Antimonopoly Act Consultation Handbook
2022.01.25
A Case where Restrictive Trading Against App Providers Became Problematic – Handling the Case Against Apple Inc. - announced by the Fair Trade Commission dated September 9, 2021 [Antitrust Case Flash Report]
2022.01.07
Recent Tends in the Subcontract Act: Focusing on the Regulation of the Terms of Trade Itself
2021.11.20
Learning from Anti-Monopoly Act Cases Consulted with the JFTC and the Cases of Violation of the Subcontract Act - Practical Points to Ensure Fairness in Inter-Business Transactions (Business Homu, January 2022)
2021.11.15
[Series] E-Commerce Practices （Points to Note in Drafting Terms and Conditions.etc.） (No. 12):Points to Note regarding Personal Data Protection (3)
2021.11.01
Examination and Analysis of Regulations against Abuse of Superior Bargaining Position 4th Edition
2021.10.15
[Series] E-Commerce Practices （Points to Note in Drafting Terms and Conditions.etc.） (No. 11):Points to Note regarding Personal Data Protection (2)
2021.09.15
[Series] E-Commerce Practices （Points to Note in Drafting Terms and Conditions.etc.） (No. 10) :Points to Note regarding Personal Data Protection (1)
2021.05.17
Private Antitrust Litigation
2021.05.10
Ronten-Taikei : The Anti-Monopoly Act Second Edition
2021.04.16
Learn through Q&A : A Practical Guide to the Subcontracting Act for each Industry
2021.03.01
COVID-19 and Corporate Legal Affairs – Legal Issues during/after COVID-19
2020.11.20
Corporate Compliance on Utilization of External Human Resources - Intersection of Antimonopoly Act and Employment Law
2020.11.11
Gun-jumping Rule and Examples of Enforcement Outside of Japan
2020.10.31
Practical Guide to the 2016 and 2019 Antimonopoly Act Amendments
2020.10.23
Flash Report on Anti-Monopoly Case: Justification of Voluntary Restrictions by Trade Associations Based on their Purposes and Methods ― Announcement of the JFTC on June 23, 2020
2020.10.21
The Eight Key Points that Should be Immediately Disseminated to Main Subcontracting Entrepreneurs - Compliance with the Subcontract Act and the Trends of the Anticipated Law Enforcement during the COVID-19 Pandemic (Business Homu, December 2020)
2020.09.25
Reduction System for Cooperation in Investigation
2020.08.21
Viewpoints in Reviewing Competition Law Compliance Systems at Companies
2020.06.27
Lawyers' Knowledge on Competition Law Practice
2020.04.25
Recent Developments Concerning the Subcontract Act and Points to Note in Terms of Compliance
2019.10.21
DOJ Dawn Raid Preparation and Response Checklist (Part 2) ~Contemplating Compliance Programs for Global Corporations based on Overseas Practice of Competition Laws~
2019.10.07
[Expert Analysis] Digital Platforms Must Heed Japanese Antitrust Law Updates
2019.09.21
DOJ Dawn Raid Preparation and Response Checklist (Part 1) ~Contemplating Compliance Programs for Global Corporations based on Overseas Practice of Competition Laws~
2019.07.01
To Operate a Business Properly - A Review of the Key Points of the Anti-Monopoly Act
2019.07.01
Points to Note in Employing Freelancers from the Perspective of the Anti-Monopoly Act and the Subcontract Act
2019.04.01
Competition Law Compliance Program for Companies Diversifying Globally
2019.03.01
Schmidt's Deodorant Company (Natural Deodorant Products), Report #6127, NAD/CARU Case Reports (10/27/2017) - A Case Study where Advertising Claims based on General Customers' Reviews were Found Inappropriate in the US -
2019.02.01
Introduction of the Commitment Procedure under the Anti-Monopoly Law
2018.10.03
Points to Note in the Consumer Contract Act Amended in 2018 and Measures Required of Corporations
2018.04.21
A Textbook for First-Year Legal Department Staff and In-house Lawyers – The Subcontract Act and the Antitrust Law
2017.10.25
Special Dialogue:Measures for the Changing Competition Environment – Clarification of the Safety Zone
2017.07.10
An up-close coverage on officers investigating subcontract transactions - A deeper examination into the bullying of small and medium-sized enterprises (Commentator)
2015.03.01
The Antimonopoly Act (Supervising Editor)
2014.06.20
Ronten-Taikei:The Anti-Monopoly Act
2013.01.01
The Cartels and Leniency Review

MORE

Other publications about Protection of Personal Information

2025.08.04
Doing Business In... 2025 Trends and Developments
2025.06.27
Status of Triennial Review of the Act on the Protection of Personal Information
2025.04.01
Current Status of “The Every-Three-Year Review ” of the Act on the Protection of Personal Information: Changes in Enforcement Proceedings and Effects for AI Development, etc.
2025.01.28
A Study on Guidelines for Identifying Sensitive Personal Information
2024.07.19
Doing Business In... 2024 Trends and Developments
2024.06.19
[Column] "Personal Information" and "Privacy" that HR Staff Members Should Understand
2024.01.12
Business Use of Generative AI (Part II) - Formulation of Internal Rules Regarding Use of Generative AI
2024.01.12
Business Use of Generative AI (Part I) - Legal Considerations for Use Cases for Each Department
2023.12.30
Background and Challenges to the Promotion of Cancer Screening in the Workplace – Introduction to proper handling of non-statutory health information
2023.08.24
Thematic-based: Legal Practice in the Healthcare Business
2023.07.18
Doing Business In... 2023 Trends and Developments
2023.07.06
Handling of Genetic Information in the Workplace and Practical Actions -- Approach Using Hypothetical Cases Concerning Hereditary Tumors Symposium - From a Lawyer’s Perspective (essay based on the presentation at Symposium No. 3, the Second Academic Congress, The Japan Association of Occupational Health Law)
2023.04.03
Handling of Personal Data in the “Metaverse”
2022.07.26
Standard Agreement on the Extraterritorial Transfer of Personal Information
2022.07.12
Doing Business In... 2022 Trends and Developments
2022.07.04
Legal Compliance of Workplace Surveillance in China -From a Personal Information Protection Perspective
2022.03.14
A Few Key Points of the China Personal Information Protection Law
2021.12.22
Personal Information Protection Law of China (2) – Processing of Personal Information and Consent by the Data Subject -
2021.11.24
Measures on Security Assessment of Cross-Border Data Transfers (Draft for Comment) - Basic Points to Note -
2021.11.15
[Series] E-Commerce Practices （Points to Note in Drafting Terms and Conditions.etc.） (No. 12):Points to Note regarding Personal Data Protection (3)
2021.10.28
Personal Information Protection Law of China (1) - Basic Points to Note -
2021.10.15
[Series] E-Commerce Practices （Points to Note in Drafting Terms and Conditions.etc.） (No. 11):Points to Note regarding Personal Data Protection (2)
2021.09.15
[Series] E-Commerce Practices （Points to Note in Drafting Terms and Conditions.etc.） (No. 10) :Points to Note regarding Personal Data Protection (1)
2021.04.01
It is not Too Late to Learn: Cookie Compliance
2021.03.01
Corporate Governance and Internal Investigations in Europe (3) – Protection of Whistleblowers
2021.03.01
Corporate Governance and Internal Investigations in Europe (2) – Protection of Personal Data
2021.03.01
Corporate Governance and Internal Investigations in Europe (1) - Overview
2021.03.01
COVID-19 and Corporate Legal Affairs – Legal Issues during/after COVID-19
2017.04.01
Decision by the Third Petty Bench of the Supreme Court on January 31, 2017 and “Right to be Forgotten”

MORE

Other publications about M&A

2023.08.24
Thematic-based: Legal Practice in the Healthcare Business
2022.07.25
[Legal] New Trends in ESG and M&A (Oh-Ebashi LPC & Partners)/[2] Points on Sustainability Information Disclosure and the Required Legal Practice
2021.11.02
International Comparative Legal Guides: Private Equity 2021, Japan Chapter

MORE

Contact us

ページTOPへ